Shize Pan
238th Jiefang Road
Wuhan, 430060, China
Wuhan, 430060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Systematic analysis of histone acetylation regulators across human cancers.
Journal: BMC cancer
Published: April 02, 2023
Eriocitrin attenuates sepsis-induced acute lung injury in mice by regulating MKP1/MAPK pathway mediated-glycolysis.
Journal: International immunopharmacology
Published: December 04, 2022
Mitophagy: A novel perspective for insighting into cancer and cancer treatment.
Journal: Cell proliferation
Published: June 12, 2022
Squamous cell carcinoma predicts worse prognosis than adenocarcinoma in stage IA lung cancer patients: A population-based propensity score matching analysis.
Journal: Frontiers in surgery
Published: May 14, 2022
Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance.
Journal: Frontiers in pharmacology
Published: May 03, 2022
Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma.
Journal: Frontiers in genetics
Published: March 20, 2022
Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery.
Journal: Frontiers in oncology
Published: March 14, 2022
Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma.
Journal: Scientific reports
Published: February 22, 2022
Comprehensive analysis reveals the potential value of inflammatory response genes in the prognosis, immunity, and drug sensitivity of lung adenocarcinoma.
Journal: BMC medical genomics
Published: February 11, 2022
Single-cell RNA sequencing analysis revealed cellular and molecular immune profiles in lung squamous cell carcinoma.
Journal: Translational oncology
Published: January 21, 2022
Comprehensive molecular analysis of a four-pyroptosis-gene signature with prognosis and immune landscape in lung adenocarcinoma.
Journal: Genomics
Published: December 13, 2021
Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Journal: Frontiers in immunology
Published: April 09, 2021
Last Updated: 09/26/2026